Sharps Technology Completes Private Funding Round on August 25, 2025

According to industry sources, Sharps Technology completed a Private funding round on August 25, 2025. Notable investors in this round include Pantera Capital, ParaFi Capital, Borderless Capital, CoinFund, Arrington Capital, Primitive Ventures, Hypersphere Ventures, FalconX, RockawayX, and Quantstamp.Sharps Technology is a NASDAQ-listed medical device company (Ticker: STSS), specializing in the research, development, and manufacturing of innovative safety syringes. The company's core mission is to reduce the risk of disease transmission caused by needlestick injuries through its proprietary technology, safeguarding healthcare professionals, patients, and the public, while enhancing the accuracy and efficiency of drug delivery.It is noteworthy that following the completion of this round, Sharps Technology rapidly expanded its fundraising to USD 1 billion and launched a digital asset reserve strategy. On August 25, 2025, the company secured over USD 400 million in PIPE private placement financing to establish a SOL treasury. By September 2, 2025, its SOL holdings exceeded 2 million tokens, underscoring the company’s robust positioning in the digital asset sector.This financing not only highlights institutional recognition of Sharps Technology’s leadership in medical devices but also reflects the company’s active expansion into digital asset management, laying a foundation for future diversified growth.